1 / 38

JAUNDICE AND THE NEWBORN

JAUNDICE AND THE NEWBORN. Abbey Rupe, MD. Objectives. Definitions Prevention Risk factors Assessment Treatment. What is jaundice?. Hyperbilirubinemia Indirect/Unconjugated Direct/Conjugated Considered elevated if direct portion is >20% of total bilirubin level

sanders
Download Presentation

JAUNDICE AND THE NEWBORN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. JAUNDICE AND THE NEWBORN Abbey Rupe, MD

  2. Objectives • Definitions • Prevention • Risk factors • Assessment • Treatment

  3. What is jaundice? • Hyperbilirubinemia • Indirect/Unconjugated • Direct/Conjugated • Considered elevated if direct portion is >20% of total bilirubin level • Scope won’t be discussed in this lecture

  4. Definitions • Unconjugated • Physiologic jaundice • Most babies develop some jaundice • Mean peak of 5-6 mg/dl between 60-72 hr of life • Breast-feeding jaundice • Decreased calories, increased enterohepatic circulation • Breast-milk jaundice • Prolonged after 2-3 weeks of age • ?? Protein in breast milk that increases enterohepatic circulation

  5. Definitions • Pathologic • Jaundice appearing in first 24 h of life • TSB > 95th percentile for age • TSB increasing at rate >0.2 mg/dl/h or > 5 mg/dl/d • Elevated direct component • Jaundice persisting > 2 weeks in full-term infants • Exception: breast-milk jaundice • “Severe” hyperbilirubinemia • Generally considered to be TB >25-30

  6. Complications of untreated jaundice • Bilirubin-induced neurologic dysfunction (BIND) • Bilirubin crosses BBB and binds to brain tissue • Risk increased when TB >25-30 • Acute bilirubin encephalopathy (ABE) • Initial phase: lethargy, hypotonia, decreased movement, poor suck • Intermediate phase: stupor, irritability, increased tone (retrocolis and opisthotonos), fever • Advanced phase: deep stupor or coma, inability to feed, shrill cry, apnea, seizures • **potentially reversible!

  7. Complications • Chronic bilirubin encephalopathy (kernicterus) • Choreoathethoid cerebral palsy • Sensorineural hearing loss • Palsy of vertical gaze • Dental enamel hypoplasia • Up to 10% mortality • Most (but no all) infants with kernicterus previously manifested symptoms of ABE

  8. Why do neonates become jaundiced? • Increased bilirubin production • More RBCs + shorter RBC life span = increased turnover and increased bilirubin • Decreased bilirubin clearance • Deficiency of UGT • UGT activity at 7 days of age is approx 1% of adult • Reaches adult levels around 14 days of age • Increased enterohepatic circulation

  9. Pathologic jaundice--causes • Rh or ABO incompatibility • Enzyme deficiencies: G6PD, pyruvate kinase • Hemoglobinopathies • Infection • Increased RBC load • Cephalohematomas, etc • Polycythemia • Infants of diabetic mothers

  10. Pathologic jaundice--causes • Disorders of bilirubin clearance • Crigler-Najjar, Gilbert • Metabolic and endocrine • Galactosemia, hypothyroidism • Increased enterohepatic circulation • Breast-feeding jaundice • Conditions causing GI obstruction or decreased motility

  11. Risk factors for severe jaundice • Major: • Predischarge bili in high-risk zone • Observed jaundice in 1st 24 hours of life • Blood group incompatibility w/ positive DAT • Previous sibling required ptx • Cephalotematoma or other significant bruising • Exclusive breastfeeding (esp if not going well and weight loss is excessive) • East Asian race

  12. Risk factors for severe jaundice • Minor risk factors • Predischarge bili in high-intermediate risk zone • GA 37-38 weeks • Jaundice observed before discharge • Previous sibling with jaundice • Macrosomic IDM • Maternal age ≥ 25 years • Male gender

  13. Risk factors for severe jaundice • DECREASED risk • Pre-discharge bili in low-risk zone • GA ≥ 41 weeks • Exclusive bottle feeding • Black race • Discharge from hospital after 72 hours

  14. Hyperbilirubinemia--prevention • Pregnant women: • ABO and Rh testing • Rhogam as indicated • screen for isoimmune antibodies • If mom is Rh- or ABO/Rh status unknown • Check blood type, Rh, and DAT on neonate (cord blood) • If DAT positive: needs frequent (q6-12hr) checking of TSB

  15. Jaundice--prevention • Newborn nursery: • Advise mothers to nurse 8-12 times per day for first several days • Evaluate for jaundice every time vitals taken (q8-12 hr)

  16. Testing for jaundice • Before discharge, ALL newborns should be assessed for jaundice (2004 AAP Practice Guideline) • Visual assessment • Need adequate ambient light or daylight fluorescent light • Subjective and not recommended as lone assessment • More difficult in darker-complected infants • TSB (total serum bilirubin) • Oftentimes drawn with metabolic screen • TcB (transcutaneous bilirubin) • Method implemented at SRHC in 2010

  17. Assessment tools • AAP bilirubin nomograms • Electronically • UpToDate calculator • BiliTool.org • Online calculator • App for iPhone or iPod touch • Palm OS

  18. Phototherapy

  19. Using the nomograms • Use total bilirubin (don’t subtract direct component) • Risk factors: • Isoimmune hemolytic disease • G6PD deficiency • Asphyxia • Significant lethargy • Temp instability • Sepsis • Acidosis • Albumin < 3.0 (if measured)

  20. Exchange transfusion

  21. Discharge and follow-up Follow-up by a “qualified health care professional” typically with PCP or mid-level provider nurse/lactation specialist home health nurse visit If follow-up cannot be ensured, may be necessary to delay discharge

  22. Anticipatory Guidance • Jaundice progresses head to toe, then as it resolves, disappears from toe to head • Testing for jaundice: blanch skin with finger • Call if: • Jaundiced to belly button • Not waking well for feeds or feeding poorly • Decreased wet diapers • Shrill cry

  23. Follow-up appointment • Weight and % change from BW • Adequacy of po intake • Pattern of voiding and stooling • Presence or absence of jaundice • +/- checking bili level • If predischarge bili was high-intermediate risk, I nearly always recheck a bili • If predischarge bili was low-risk, I rarely do • If predischarge bili was low-intermediate, I do if concerns present

  24. So . .. .you’ve reached LL.Now what? • History and physical exam • Laboratory testing • Phototherapy • Assess hydration

  25. Laboratory evaluation • Approaching or at light level: • Direct and total bilirubin • Blood type and DAT • CBC • Peripheral smear • Consider: retic count, G6PD, ETCOc • Consider: UA (for reducing substances) with culture, sepsis eval

  26. Lab evaluation • Approaching exchange levels or not responding to phototherapy • Retic, G6PD, albumin, ETCOc • UA • Sepsis eval • Elevated direct (or conjugated) bilirubin • UA and urine culture • Evaluate for sepsis if indicated by history and physical exam

  27. Treatment—Phototherapy • Mechanism of action: • Exposes skin to light of specific wavelength (425-475 nm/blue-green spectrum) • Converts bilirubin to lumirubin • Lumirubin is more soluble than bilirubin and is excreted without conjugation into the bile and urine

  28. Phototherapy options • Bili blanket • Home or hospital • Bili bed • Home or hospital • “Bank” phototherapy • Hospital only • Home vs hospital • Home is an option 2-3mg/dl below LL in infant with no risk factors and caregivers with ready access to medical care

  29. Treatment--phototherapy • Technique—bank phototherapy • Infant should wear diaper only, and diaper should be pulled down as much as possible to increase skin exposure • “baby sunglasses” • Ensure that banks of lights are at appropriate distance from infant • Infant needs to remain under lights continuously, only to be taken out for feedings • Can utilize biliblanket to continue some ptx during feeds

  30. Phototherapy • phototherapy typically results in a decline of TB of 2-3 mg/dl within 4-6 hours • Obviously, more lights = faster decline • Recheck TB within 2-6 hours of starting ptx • Then, recheck every 6-12 hours, if TB is falling • If doing home therapy, need to redraw daily • Hospitalize if surpasses LL, excessive rate of rise, or other concerns develop

  31. Phototherapy—side effects • Generally considered safe • Transient erythematous rashes • Loose stools • Hyperthermia • Increased insensible water loss • Possible retinal degeneration (hence the sunglasses) • Parents/caregivers: • some models can cause HA and nausea • Frustrating to not get to hold baby • “bronze baby syndrome” • If used on infant with cholestasis

  32. Management—assess hydration • Maintaining adequate hydration and UOP is important • Lumirubin excreted in urine > stool • Encourage breast or bottle feeding • Lactation consult prn • Supplement with EBM or formula in breastfed infants with excessive weight loss (>12%) or evidence of hypovolemia • IVF if oral intake is inadequate

  33. Phototherapy . .. When to stop? • No strict guideline • when TSB <13-14 • When TSB back to, or lower-than, level at which ptx was initiated • Sometimes at lower level if started during NB stay and treatment initiated at lower LL

  34. Phototherapy . . . When to stop? • “checking for rebound” • TB will typically re-increase by small amount (typically <1 mg/dl) after discontinuation of ptx • DON’T have to keep pt hospitalized to check for rebound, unless risk-factors present • DO check in hospital or clinic the next day if: • ptx discontinued prior to 5-6 days old (may not have reached peak yet) • Other concerns • For “nervous Nellie’s” (like myself): night before anticipated discharge, check TSB. Continue ptx until 2 or 3am, then d/c. Check bili with AM labs, should see if significant rebound present

  35. If not improving Likely that hemolysis is occurring: • Increase # banks • Labs: • Retic, G6PD, albumin, ETCOc • Sepsis eval • UA and urine culture • Add IVF • Consult pediatrician +/- neonatologist • Exchange transfusion in NICU

  36. Lab evaluation • Jaundice preset at ≥ 2-3 weeks • Total and direct bili • If direct bili elevated, evaluate for causes of cholestasis • Check NB thyroid and galactosemia; evaluate infant for signs/sx of hypothyroidism • If indirect elevated and breast-fed, potentially breast-milk jaundice • Option to give formula in place of breast milk x24 hours (controversial)

  37. ?Sunny window? • Technically. . .. NO • Risk for sunburn • Risk for hypo- or hyper-thermia

More Related